Literature DB >> 11830194

Effect of race on outcome of orthotopic liver transplantation: a cohort study.

Satheesh Nair1, Joseph Eustace, Paul J Thuluvath.   

Abstract

BACKGROUND: There is significant evidence to suggest that long-term survival after renal transplantation is significantly lower in African Americans than in other races. We aimed to establish whether there was a difference in survival in African Americans compared with other races after orthotopic liver transplantation (OLT) and whether race was an independent predictor of survival.
METHODS: We collected data from the United Network of Organ Sharing transplant registry for all liver transplants done between 1988 and 1996 in the USA. We also recorded information on age, sex, race, blood group, and cause of death for the donors and recipients.
FINDINGS: 2-year graft survival was significantly lower for African Americans (601 of 884, 68%) and Asians (266 of 416, 64%) compared with white Americans (8703 of 11762, 74%) and Hispanics (878 of 1220, 72%). 2-year and 5-year patient survival were significantly lower for African Americans (654 of 884 [74%], 270 of 565 [48%]) and Asians (287 of 416 [69%], 92 of 252 [37%]) compared with white Americans (9786 of 11762 [83%], 4357 of 7514 [58%]) and Hispanics (964 of 1220 [79%], 341 of 657 [52%]). Compared with white Americans, African American (hazard ratio 1.36, 95% CI 1.16-1.60, p<0.0001) and Asian (1.25, 1.01-1.56, p=0.03) race were independent predictors of poor survival at 2 years.
INTERPRETATION: African Americans and Asians have a worse outcome after OLT compared with white Americans and Hispanics. The higher rate of chronic rejection in African Americans and a relatively worse outcome in other minority races merits further examination.

Entities:  

Mesh:

Year:  2002        PMID: 11830194     DOI: 10.1016/S0140-6736(02)07494-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.

Authors:  Varun Saxena; Jennifer C Lai; Jacqueline G O'Leary; Elizabeth C Verna; Robert S Brown; R Todd Stravitz; James F Trotter; Kartik Krishnan; Norah A Terrault
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

2.  Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.

Authors:  Jennifer E Layden; Scott J Cotler; Shellee A Grim; Michael J Fischer; Michael R Lucey; Nina M Clark
Journal:  Transplantation       Date:  2012-02-27       Impact factor: 4.939

3.  Effects of a brief educational program on knowledge and willingness to accept treatment among patients with hepatitis C at inner-city hospitals.

Authors:  Kapil Gupta; Denise Romney; Muriel Briggs; Karen Benker
Journal:  J Community Health       Date:  2007-08

4.  The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.

Authors:  Phillip S Pang; Ahmad Kamal; Jeffrey S Glenn
Journal:  Liver Transpl       Date:  2009-09       Impact factor: 5.799

5.  Ethnic disparities in liver transplantation.

Authors:  Nyingi Kemmer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-05

6.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2002

7.  Ethnicity predicts metabolic syndrome after liver transplant.

Authors:  Claudia A Couto; Claudio L Gelape; Iliana B Doycheva; Jonathan K Kish; Paul Martin; Cynthia Levy
Journal:  Hepatol Int       Date:  2012-12-27       Impact factor: 6.047

8.  Association of genetic variants with rapid fibrosis: progression after liver transplantation for hepatitis C.

Authors:  Jennifer E Layden; Bamidele O Tayo; Scott J Cotler; Nina M Clark; Kristine Baraoidan; Scott L Friedman; Richard S Cooper
Journal:  Transplantation       Date:  2014-05-27       Impact factor: 4.939

9.  Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.

Authors:  Yong Han Paik; Kwan Sik Lee; Kwang Hyub Han; Kun Hoon Song; Myoung Hwan Kim; Byung Soo Moon; Sang Hoon Ahn; Se Joon Lee; Hyo Jin Park; Dong Ki Lee; Chae Yoon Chon; Sang In Lee; Young Myoung Moon
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

10.  Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States.

Authors:  Robert J Wong; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2009-01-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.